Showing results (281-290 of 494) with videos related to
Sort By:
Pageof 50
Drug Discovery Today. Technologies|October 15, 2015
Network and systems biology: essential steps in virtualising drug discovery and developmentChristoph Wierling, Thomas Kessler, Lesley A Ogilvie, et al.Drug Discovery Today. Technologies|December 14, 2017
Imaging the glutamate receptor subtypes-Much achieved, and still much to doStefan Gruber, Simon M AmetameyDrug Discovery Today. Technologies|December 14, 2017
Discovery and development of SV2A PET tracers: Potential for imaging synaptic density and clinical applicationsJoel Mercier, Laurent Provins, Anne ValadeDrug Discovery Today. Technologies|December 14, 2017
PPI inhibitor and stabilizer development in human diseasesJürgen BoschDrug Discovery Today. Technologies|December 17, 2018
Drawing lessons from the clinical development of antibody-drug conjugatesRobert LyonDrug Discovery Today. Technologies|December 17, 2018
Recent, non-classical, approaches to antibody lysine modificationGuilhem Chaubet, Fabien Thoreau, Alain WagnerDrug Discovery Today. Technologies|December 17, 2018
Miniaturised 'antibody'-drug conjugates for solid tumours?Mahendra P DeonarainDrug Discovery Today. Technologies|December 17, 2018
Use of pyrrolobenzodiazepines and related covalent-binding DNA-interactive molecules as ADC payloads: Is mechanism related to systemic toxicity?Paul J M Jackson, Syafiq Kay, Ilona Pysz, et al.Drug Discovery Today. Technologies|April 5, 2013
Practical Considerations For Developing Nucleoside Reverse Transcriptase InhibitorsSelwyn J Hurwitz, Raymond F SchinaziDrug Discovery Today. Technologies|September 21, 2013
Combination of ligand- and structure-based methods in virtual screeningMalgorzata N Drwal, Renate GriffithPageof 50